Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioElectronics Corporation (BIEL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00100.0000 (0.00%)
At close: 03:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0010
Open0.0011
BidN/A x N/A
AskN/A x N/A
Day's Range0.0009 - 0.0011
52 Week Range0.0005 - 0.0038
Volume7,777,414
Avg. Volume31,509,525
Market Cap56.528M
Beta (5Y Monthly)0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateJun 27, 2022 - Jun 29, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BIEL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BIOELECTRONICS CORP
    PCRX: Raising target price to $59.00PACIRA BIOSCIENCES INC has an Investment Rating of BUY; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group

    FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain. "PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx in an important market in

  • GlobeNewswire

    BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico

    FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected that they will receive their initial stocking order during the 2nd

  • GlobeNewswire

    BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements

    FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE: BioElectronics Corporation is pleased to announce that it has signed two additional international distribution partners and received a new order from its longtime distribution partner in Banglade

Advertisement
Advertisement